mPulse Mobile ranks on 100+ artificial intelligence companies to know in healthcare | 2019

Jenna Bloom and Laura Dyrda – Friday, July 19th, 2019

Artificial intelligence and machine learning are quickly becoming an integral part of healthcare delivery.

Both on the clinical care and operational side of healthcare organizations, AI has is powering technology that keeps patients safe and improves efficiency for the revenue cycle, supply chain and more.

Here are 100-plus companies in the healthcare space using artificial intelligence.

To add a company to this list, contact Laura Dyrda at

Aidoc (Tel Aviv, Israel). Aidoc provides radiologists with artificial intelligence (AI) for clinical settings. Their FDA cleared solution detects time-sensitive pathologies and prioritizes them in the radiology workflow, allowing leading health systems to improve outcomes and patient safety.

AiCure (New York City). AiCure is an AI and advanced data analytics company that uses video, audio and behavioral data to better understand the connection between patients, disease and treatment. It allows physicians to have access to clinical and patient insights.

Aiva Health (Los Angeles). Aiva Health developed Aiva, the first voice-powered care assistant. The software understands requests and instantly connects patients with the correct physician for communication.

Apixio (San Mateo, Calif.). Apixio’s AI platform transforms disparate text and coded data into actionable knowledge and health insights for better decision making.

Arterys (San Francisco). Arterys is a leader in intelligent, cloud-based medical imaging software. It created the first medical imaging cloud platform powered by artificial intelligence.

AtomWise (San Francisco). AtomWise developed AtomNet, a drug-designing technology based on convolutional neural networks. It aims to help its partners deliver better medicines faster.

Ayasdi (Menlo Park, Calif.). Ayasdi designs applications and an enterprise-grade software platform that allows healthcare organizations to analyze and build predictive models that solve complex challenges in the industry by using big data or highly dimensional data sets.

Babylon Health (London). Babylon is a digital healthcare provider that aims to create an internationally accessible and affordable health system for all. (New York City). Belong’s end-to-end patient engagement platform (PEP) for payers, providers, pharma and advocacy groups utilizes AI and machine learning to deliver hyper-personalized patient experiences. Additionally, the Belong “Beating Cancer Together” app unites 200,000 global cancer patients, caregivers and healthcare professionals, delivering AI-powered personalized news, peer support, direct access to doctors, clinical trial matching services and document management tools.

Bigfoot Biomedical (Milpitas, Calif.). Bigfoot Biomedical is the creator of the automated insulin delivery system. The company works to improve the health and safety of those suffering from Type 1 diabetes through the creation of smart devices.

BioXcel Therapeutics (New Haven, Conn.). BioXcel Therapeutics is a clinical stage biopharmaceutical company that uses AI to create medicines in neuroscience and immuno-oncology.

Bot M.D. (Singapore). Bot M.D. is an AI application that acts like an assistant. It can answer clinical questions, transcribe dictated case notes and automatically organize images and files.

Buoy Health (Boston). Buoy is an artificial intelligence computational platform that allows ill users to understand their symptoms, get answers and form a treatment plan through chatting.

Butterfly Network (Guilford, Conn.). Butterfly Network is a digital health company that works to make medical imaging universally accessible and affordable. The company created Butterfly iQ, the world’s first handheld whole-body ultrasound system that connects to a smartphone.

Cardinal Analytx Solutions (Palo Alto, Calif.). Cardinal Analytx Solutions, an artificial intelligence-enabled health insights company, helps organizations predict and identify future health risks, improve patient outcomes and costs and develop an action plan for reducing such determinants.

Cathworks (Aliso Viejo, Calif.). Cathworks delivers an image-based approach for assessing FFR (functional flow reserve) in the cath lab using data from standard angiograms. Cathworks’ CE marked and FDA approved solution creates a personalized 3D model of each patient’s arteries and uses algorithms to simulate blood flow and assess the impact of arterial blockages without the use of a pressure wire.

Change Healthcare (Nashville, Tenn.). Change Healthcare is a healthcare technology company delivering software, analytics and solutions to improve the healthcare system. The company includes artificial intelligence in several products, most recently unveiling Claims Lifecycle Artificial Intelligence in February.

Clarify Health Solutions (San Francisco). Clarify Health Solutions uses technology and an analytics platform to solve many of the complex challenges facing healthcare professionals and to personalize and optimize patient care journeys.

Cloud Pharmaceuticals (Research Triangle Park, N.C.). Cloud Pharmaceuticals uses new, innovative cloud computing technology to accelerate the process of designing drugs and drug candidates. The process is called Quantum Molecular Design.

CloudMedx (Palo Alto, Calif.). CloudMedx uses AI, data-driven models to improve clinical insights, revenue cycle management and patient care.

Curemetrix (La Jolla, Calif.). Curemetrix is working toward developing the next generation of medical image analysis technology. In particular, it uses a patent-pending algorithm to create more precise and advanced tools for mammography.

Cyrcadia Health (Reno, Nev.). Cyrcadia Health designed a wearable, intelligent breast monitor device that uses breast patches that identify circadian patterns within breast cells to keep physicians aware of patients’ breast health.

Day Zero Diagnostics (Boston). Day Zero Diagnostics is develoipng a rapid in-vitro diagnostic for identification of bacterial pathogens and antibiotic susceptibility profiles. The company combines genomic next generation sequencing (NGS) and machine learning to combat antimicrobial resistant infections, enabling physicians to switch from harmful and costly broad-spectrum antibiotics to targeted antibiotic therapy within hours instead of days.

Deep Genomics (Toronto, Canada). Deep Genomics uses their AI platform to rapidly direct them to the best drug candidates. The company is designing new ways of detecting and treating disease using biologically accurate AI technology.

Deep Lens (Columbus, Ohio). Deep Lens manages the largest digital pathology cloud platform that allows pathology groups to collaborate on cancer research.

Desktop Genetics (Cambridge, Mass.). Desktop Genetics works to discover and treat the root genetic causes of human disease and has emerged as a leader in genome editing technology. Its core technology is DESKGEN AI, which powers DESKGEN CRISPR that helps with drug discovery and functional genomics.

Digital Reasoning (Nashville, Tenn.). In healthcare, Digital Reasoning deploys AI-powered care management software within health systems to augment the care team and accelerate the entire care process, delivering a positive impact on clinical, financial and operational outcomes.

DreaMed Diabetes (Petah Tikva, Israel). DreaMed Diabetes’ management platform uses unique cloud-based AI technology to provide patients with insulin treatment insights and plans. It simplifies the complexity of diabetes data.

Enlitic (San Francisco). Enlitic connects human and artificial intelligence and data to advance medical diagnostics. The company collects and analyzes data and designs medical software that allows physicians to diagnosis faster and more accurately.

FDNA (Boston). FDNA uses artificial intelligence to analyze genetic, phenotypic information databases to detect physiological patterns that reveal disease-causing genetic variations.

Flatiron Health (New York City). Flatiron Health developed OncoCloud, a shared technology platform that connects community, oncologists, academics, hospitals, life science researchers and regulators to better treat cancer.

Futurus Group (Irvine, Calif.). Futurus Group is the first AI machine-learning company to develop an algorithm to predict gratitude within a hospital’s grateful-patient program. Futurus Group’s patent-pending G2G (Gratitude to Give) algorithm leverages data within a hospitals EMR, donor CRM and patient satisfaction data to predict individuals most likely to make a gift to a hospital or medical center. (Palo Alto, Calif.). developed an application that collects personal health data that can be used by medical researchers to accelerate discovery or as health insights for the user.

Ezra (New York City). Ezra designed full-body, MRI technology that detects up to 13 cancers in women and 11 in men.

FitGenie (Atlanta). FitGenie is an AI, nutrition application that aids people by providing tools and instructions for maintaining and optimizing nutritional health. More specifically, it is a smart calorie counter that tells users what to eat to reach their goals.

Freenome (South San Francisco, Calif.). Freenome seeks to transform the way medicine is practiced by using artificial intelligence, biology and computer science to detect disease earlier and more accurately.

Gauss Surgical (Menlo Park, Calif.). Gauss Surgical is the leading developer of an AI-enabled platform for real time monitoring of surgical blood loss.

Genoox (Palo Alto, Calif.). Genoox delivers a data-driven, cloud-based solution that unlocks the value of genomics. The company’s adaptive AI solution leverages proprietary datasets that transform raw genetic information into actionable real world evidence enabling customers to develop customized clinical NGS genetic applications with accelerated turnaround time delivering insights within hours instead of weeks. (San Francisco). provides clients with an on-demand coach, therapist and psychiatrist for instant care.

H1 (New York City). H1 is a live data insights platform for diseases, driven by machine learning. The platform is able to find data from any public clinical and scholarly database in the world, drawing on curated data from “hundreds of thousands” of website profiles and conference presentations. H1’s tools search across more than 250,000 academic researchers, 250,000 clinical trials, 50 million journal articles, and 750,000 clinicians and physicians. (Mountain View, Calif.). is the creator of the leading open source data science and machine learning platform, Driverless AI.

Healint (Singapore). Healint designed the leading migraine application, Migraine Buddy, which tracks users’ migraines, understands triggers and shares migraine history with physicians to better treat and efficiently improve the invisible pain.

Health at Scale (San Jose, Calif.). Health at Scale uses machine intelligence to deliver precision care by matching patients to the right treatments by the right providers at the right times.

Health Fidelity (San Mateo, Calif.). Health Fidelity uses technology and expertise to allow organizations participating in Medicare Advantage, ACA commercial, Managed Medicaid or Medicare ACO programs to provide risk adjustment solutions.

HealthReveal (New York City). HealthReveal uses artificial intelligence to reduce costs, improve outcomes and quality of life and save lives for the chronically ill.

IBM Watson Health (Chicago). IBM Watson Health aims to solve health challenges using data, analytics and AI. The company works with more than 300 hospitals and healthcare organizations to make decision based on data.

iCAD (Nashua, N.H.). iCAD is a global medical technology leader that uses artificial intelligence to provide cancer detection and therapy solutions so physicians can detect cancers earlier.

IDx (Coralville, Iowa). IDx developed the first automated diabetic retinopathy diagnostic AI machine called IDx-DR. The company works to transform healthcare through the automation of medical diagnosis and treatment.

Imperativ (New York City). Imperativ’s Enterprise Intelligence Platform delivers digital twin modules and associated applications that connect and optimize the internet of medical things for decision making.

Innovaccer (San Francisco). Innovaccer is a healthcare data activation company that works to improve care delivery by making full use of all the data the healthcare industry has collected.

Inovalon (Bowie, Md.). Inovalon is a healthcare technology company designing platforms to empower data-driven healthcare. The company’s leading ONE Platform allows clients and partners to use datasets, analytics and technologies to improve healthcare outcomes and economics.

Insightin Health (Baltimore). Insightin Health created the only existing AI platform for members’ complete lifecycle. The platform delivers a personalized experience using health data and social determinants to identify the best ways to communicate with others.

Inspiren (New York City). Inspiren is the inventor of iN, an automated patient safety monitoring device that aims to reduce injuries and deaths by ensuring patients receive proper care.

Jvion (Johns Creek, Ga.). Jvion uses prescriptive analytics to prevent harm and lower costs. Its technology identifies patients on a risk trajectory, determines if that trajectory can be changed and identifies possible interventions, if applicable.

K Health (New York City). K Health developed K, the first personalized healthcare application that allows patients to check their symptoms, explore treatment options and chat with doctors for free.

KenSci (Seattle). KenSci uses AI to help providers and payers intervene earlier and at lower costs. Its platform helps uncover clinical, operational and financial risks by aggregating data.

Lunit (Seoul, South Korea). Lunit is a medical AI software company that uses cutting-edge technology and medical data to discover, design and develop imaging biomarkers.

Massive Bio (New York City). Massive Bio is a marketplace that connects oncology patients and their treating oncologist to the cutting edge advanced care options and clinical trials while enabling enterprises to get access to patients and their information to enhance oncology research. Massive Bio resides at the intersection of patient acquisition, artificial intelligence based scalable pre-screening, operationalization support and real world data to connect patients to oncology trials. 

MaxQ AI (Andover, Mass.). MaxQ AI is a leader in medical diagnostic AI. The company’s software uses artificial intelligence to interpret medical images to help physicians make more accurate and faster diagnoses of strokes, brain trauma and other conditions.

Medable (Palo Alto, Calif.). Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of traditional ePRO, eCOA, EDC, and eSource with an intelligent and unified end-to-end (E2E) platform for clinical trial execution. Medable’s E2E platform connects patients, sites, CRO’s and sponsors to work together as a connected and empowered team in clinical research, to bring new medicines to patients faster.

Medalogix (Nashville, Tenn.). Medalogix is a pioneer data science company focusing on home health and hospice. Its technology identifies risk, creates action, improves patient outcomes and delivers ROI.

Medasense (Israel). Medasense’s NOL Index is the first objective pain assessment index for accurate and personalized pain care.

MedAware (Israel). MedAware’s technology uses big data analytics and machine learning algorithms to analyze electronic medical records to learn how physicians treat patients to identify and eliminate a wide range of medication errors.

Medial EarlySign (Hod Hasharon, Israel). Medial EarlySign helps healthcare systems with their early detection and prevention of high-burden diseases. The company’s machine learning-based software finds subtle, early signs of elevated patient risk trajectories in routine, existing EHR and lab data.

MedWhat (San Francisco). MedWhat is a medical artificial intelligence company that is building an algorithmic architecture to achieve human-level intelligence in medicine. The software acts as a personal assistant by answering medical and health questions for consumers and doctors. (San Jose, Calif.). Mendel is a network of research sites powered by AI and clinical insights that works to unlock the full potential of clinical data relevant to cancer research.

mPulse Mobile (Encino, Calif.). mPulse is the leading developer of conversational AI solutions for the healthcare industry. It improves health outcomes and business efficiencies.

Myia Labs (San Francisco). Myia Labs is an intelligent health monitoring platform that helps prevent illness, manages chronic conditions and redefines quality of life by transforming real-world data into clinical, objective insights.

NarrativeDx (Austin, Texas). NarrativeDx uses AI to identify insights from patient hospital experience feedback to increase ranking, scores and referrals and reduce nurse turnover.

NextHealth Technologies (Denver). NextHealth’s AI and machine learning analytics platform combines data-driven decision making into workflow to improve healthcare affordability.

Notable (San Mateo, Calif.). Notable uses wearable technology, voice interface, friction free integrations and artificial intelligence to make patient-clinician interaction more efficient and effective.

NuMedii (San Mateo, Calif.). NuMedii is a leader of using big data, AI and biology to accelerate the discovery of precision therapies and drugs.

Numerate (San Bruno, Calif.). Numerate uses AI technology to simplify the complex process of molecular drug design.

Olive (Colorado Springs, Colo.). Olive is a custom software solution provider that offers a list of services that empowers organizational growth by building their technology engines.

Pager (New York City). Pager simplifies the healthcare experience by connecting patients and their care team in a single AI chat to make smarter and faster health decisions.

Paige.AI (Franklin D. Roosevelt Island, N.Y.). Paige.AI uses artificial intelligence to help pathologists work more efficiently, researchers discover new insights and clinicians improve patient care.

PathAI (Boston). PathAI develops technology that helps pathologists make rapid and accurate diagnoses. It also helps patients receive the most personalized, effective treatment for their condition.

Pathway Genomics (San Diego). Pathway Genomics provides physicians and their patients with actionable and accurate precision healthcare information to improve and maintain health and wellness.

Pearl (Columbus, Ohio). Pearl uses care management services and remote health, home monitoring technology to effectively and efficiently provide wider quality access. The company helps government agencies and commercial enterprises provide a wider access of quality healthcare to all populations.

Picwell (Philadelphia). Picwell’s technology simplifies the complex benefits decision-making process by matching users with their optimal plan.

Potrero Medical (Hayward, Calif.). Potrero Medical is a predictive health company that develops smart sensors and artificial intelligence. It is currently creating a predictive health platform to help physicians better predict adverse outcomes in critical care settings.

Prognos (New York City). Prognos maintains the largest sources of lab data across 50 disease areas with records for 200 million patients.

Proscia (Philadelphia). Proscia developed Concentriq, a digital pathology platform, and AI applications that have and continue to transform the practice of pathology by focusing on personalized, data-centric medicine.

Pure Storage (Mountain View, Calif.). Pure Storage, a leading data storage company, allows its clients to efficiently deliver real-time secure data to perform operations.

QuartzClinical (Chicago). QuartzClinilcal uses advanced technology to help users achieve better outcomes through more cost-efficient and effective measures. The software uses predictive models, financial insights and personal health records to help make better clinical decisions

Qventus (Mountain View, Calif.). Qventus uses artificial intelligence and machine learning to help healthcare organizations operate more efficiently and simply.

Recondo Technology (Denver). Recondo Technology’s revenue cycle content engine intelligently automates the healthcare revenue cycle using a combination of AI technologies that include robotic process automation, clinical language processing and machine learning models based on extensive domain expertise. Among the first companies to develop AI specifically for the healthcare revenue cycle, today Recondo’s accurate, automated and actionable solutions replace expensive manual communication between payers and providers with high volume, high speed transactions in over 900 organizations.

Renalytix AI (Cardiff, United Kingdom). Renalytix AI develops artificial intelligent clinical diagnostic solutions for kidney disease. Its products improve risk assessment, clinical care and patient stratification for drug clinical trials.

ReveKnow (Lake Forest, Calif.). ReveKnow provides low-cost access to advanced machine learning algorithms that can predict a patient’s propensity to pay a bill, calculate percentage to FPL for presumptive charity, or estimate the probability that a denied account can be overturned. All of these services are designed for smaller budget-conscious hospitals to optimize their limited resources and focus first on the accounts most likely to produce a positive outcome.

Risalto Health (New York City). Risalto Health’s AI platform uses big data to identify the best providers and advice on care for patients suffering from neck, knee and hip pain problems.

Robin Healthcare (Berkeley, Calif.). Robin Healthcare created Robin, an AI device that completes all clinical documentation and billable notes for physicians during appointments with patients.

Sensely (San Francisco). Sensely is an application that intelligently connects insurance plan members with health related advice and resources and insurance services.

Sentrian (Australia). Sentrian provides organizations’ employees with the tools, skills and support to work technology. It provides the pieces for companies to build their IT system and grow their business.

SkinIO (Chicago). SkinIO is a mobile application that takes approximately five minutes to perform a full-body scan of moles or other concerning skin marks by using camera taken images. It also allows physicians to track any changes in skin condition.

SkinVision (Amsterdam). SkinVision’s combined technology and knowledge helps users check their skin for signs of skin cancer with instant results on a smartphone.

SmartPlate (Philadelphia). SmartPlate is the first intelligent wellbeing platform that uses advanced photo recognition and AI technology to identify, weigh and analyze anything users eat. The device instantly tracks calories by using a mobile application and a smart plate.

Sopris Health (Denver). Sopris Health developed the first AI medical scribe technology that works to improve clinical efficiency and decrease administrative burden.

Spring Health (New York City). Spring Health created and implements Precision Mental Healthcare, a method of accurately predicting the right treatment and accelerating mental health recovery by using the same scientific principles behind precision medicine.

Suki (Redwood City, Calif.). Suki is an artificial intelligence-powered, voice-enabled digital assistant for doctors that enables physicians to focus on patient care by reducing administrative burden. It’s personalized for each doctor, gets smarter with ongoing use, and can be scaled rapidly and inexpensively. 

Tagnos (Aliso Viejo, Calif.). Tagnos developed a clinical logistics automation solution to orchestrate care delivery. The application predicts and optimizes patient flow.

Touchkin (Bengaluru, India). Touchkin’s Wysa is a pioneer AI-driven empathetic, compassionate conversation coach that instantly helps users improve their mental health.

TrialJectory (New York City). TrialJectory is an AI-based trial matching platform that uses cancer patients’ self-reported medical records to facilitate clinical trial search, matching and enrollment.

twoXAR (Mountain View, Calif.). twoXAR is an artificial intelligence-driven drug discovery company that uses its platforms to identify promising drug candidates, de-risk opportunities and progress drug candidates to clinics.

Univfy (Los Altos, Calif.). Univfy is dedicated to helping women and couples wanting to have a baby increase IVF access, success and affordability through an AI platform. The software allows physicians to form accurate, personalized IVF treatment prediction plans.

Verge Genomics (South San Francisco). Verge Genomics uses advanced machine learning, computational genomics and new insights into neuroscience to reduce the time and cost of drug discovery for patients suffering from neurodegenerative disease.

VIDA Diagnostics (Coralville, Iowa). VIDA Diagnostics provides clients with software and services that can aid in early detection, evaluation and treatment planning of lung disease.

VisiQuate (Santa Rosa, Calif.). VisiQuate helps its clients achieve peak business health through artificial intelligent technology that integrates data and presents it as role-personalized insights and actionable workflows. (San Francisco). uses artificial intelligence-powered products to synchronize stroke care and improve access to life-saving therapies. It detects and alerts stroke teams and allows them to communicate in real time.

Wellframe (Boston). Wellframe uses AI technology and user data to generate real-time insights for care teams to improve health quality and outcomes.

Welltok (Denver). Welltok is a data-driven enterprise company that allows users to get actively involved in their health with the Consumer Activation Platform. It is a single platform for personalized health and wellbeing resources that powers growth and retention initiatives and improves healthcare value.

Woebot Labs (San Francisco). Woebot Labs aims to make mental health accessible to all with its Woebot application. It gives users daily lessons and check-ins and allows them to have conversations to think through situations and improve mental wellness.

Your.MD (London). Your.MD is a free mobile application that uses AI to give users health formation to help them make the best health choices.

Zebra (Lincolnshire, Ill.). Zebra’s products, software and services help healthcare professionals improve patient outcomes and business results by connecting them with assets and data.

Zephyr Health (Phoenix). Zephyr Health’s AI platform merges and analyzes public and private data sets for the Life Sciences industry. The company was acquired by Anju Software in 2018.

Zingbox (Mountain View, Calif.). Zingbox delivers am AI powered cloud-based platform which provides healthcare organizations with visibility, tracking, management and cybersecurity capabilities for the Internet of Things (IoT). The company’s comprehensive solution enables service providers in healthcare to deliver uninterrupted and secure critical care and service to patients and customers and gain organization-wide operational efficiencies.


Will Support Rapid Expansion of Vynca’s Advance Care Planning Solution

PALO ALTO, Calif., June 19, 2019 /PRNewswire/ — Vynca, the nation’s leading advance care planning solution, announced today that it has secured $10.3 million in Series B funding from First Trust Capital Partners, OCA Ventures, and Spectrum Health Ventures, in addition to key strategic individual investors. Current Vynca investors, including Generator Ventures and the Ziegler LinkAge Longevity Fund also participated. The funding will help fuel the company’s expansion into new geographies and drive new product development. Rachel Kern of First Trust Capital Partners, Phil Fogg Jr. of Marquis Companies, and Arnie E. Burchianti, II will join the Company’s Board of Directors. Dr. Scott Lancaster of Spectrum Health Ventures will join as a Board Observer.

Vynca’s end-to-end solution supports health care organizations to implement and scale high-quality advance care planning so that every person’s care preferences are honored at the end-of-life. Vynca technology supports education and engagement in advance care planning conversations, shared decision making, digital completion of documents, and ensures universal document accessibility for individuals, their caregivers, and health care providers across the care continuum.

“We’re pleased to receive the support and insight from these highly strategic health care investors who share our vision of creating a national advance care planning network,” stated Ryan Van Wert, M.D., co-founder and CEO of Vynca. “Our continued growth will ensure that more individuals have their voices heard, and that health care providers have immediate access to care preferences, so that every person’s end-of-life wishes are known and honored.”

Partnering with over 80 hospitals, as well as health plans, ACOs, and five state registries, Vynca clients are realizing an impact in terms of higher quality of care at the end-of-life and the avoidance of unwanted health care interventions.

“We are excited to partner with Vynca as the company continues to build on their position as the leading advance care planning solution,” said Rachel Kern of First Trust Capital Partners. “Vynca’s state registry partnerships and impressive growth are a testament to how they are setting a new standard for end-of-life care, ensuring that accurate care plans are available in critical moments. We look forward to being part of Vynca’s continued growth and success.”

“Spectrum Health Ventures supports innovations that can reduce cost, improve quality, and increase patient engagement and satisfaction,” said Scott Lancaster, M.D., clinical director for Spectrum Health Ventures. “We are proud to partner with Vynca, whose impressive growth and innovative platforms are providing national leadership by reflecting patient preferences for end-of-life care.”

CONTACT: Emelia Altschul, 914-260-1621,